Biology Reference
In-Depth Information
31. Wang HW, Noland C, Siridechadilok B, Taylor DW, Ma E, Felderer K, Doudna JA, Nogales
E (2009) Structural insights into RNA processing by the human RISC-loading complex. Nat
Struct Mol Biol 16:1148-1153
32. MacRae IJ, Ma E, Zhou M, Robinson CV, Doudna JA (2008) In vitro reconstitution of the
human RISC-loading complex. Proc Natl Acad Sci U S A 105:512-517
33. Maniataki E, Mourelatos Z (2005) A human, ATP-independent, RISC assembly machine
fueled by pre-miRNA. Genes Dev 19:2979-2990
34. Zhang H, Kolb FA, Brondani V, Billy E, Filipowicz W (2002) Human Dicer preferentially
cleaves dsRNAs at their termini without a requirement for ATP. EMBO J 21:5875-5885
35. Hammond SM, Bernstein E, Beach D, Hannon GJ (2000) An RNA-directed nuclease medi-
ates post-transcriptional gene silencing in Drosophila cells. Nature 404:293-296
36. Khvorova A, Reynolds A, Jayasena SD (2003) Functional siRNAs and miRNAs exhibit
strand bias. Cell 115:209-216
37. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD (2003) Asymmetry in the
assembly of the RNAi enzyme complex. Cell 115:199-208
38. Matranga C, Tomari Y, Shin C, Bartel DP, Zamore PD (2005) Passenger-strand cleavage
facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell 123:
607-620
39. Rand TA, Petersen S, Du F, Wang X (2005) Argonaute2 cleaves the anti-guide strand of
siRNA during RISC activation. Cell 123:621-629
40. Leuschner PJ, Ameres SL, Kueng S, Martinez J (2006) Cleavage of the siRNA passenger
strand during RISC assembly in human cells. EMBO Rep 7:314-320
41. Liu J, Carmell MA, Rivas FV, Marsden CG, Thomson JM, Song JJ, Hammond SM, Joshua-
Tor L, Hannon GJ (2004) Argonaute2 is the catalytic engine of mammalian RNAi. Science
305:1437-1441
42. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T (2001) Functional anat-
omy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate.
EMBO J 20:6877-6888
43. Orban TI, Izaurralde E (2005) Decay of mRNAs targeted by RISC requires XRN1, the Ski
complex, and the exosome. RNA 11:459-469
44. Fabian MR, Mathonnet G, Sundermeier T, Mathys H, Zipprich JT, Svitkin YV, Rivas F, Jinek
M, Wohlschlegel J, Doudna JA et al (2009) Mammalian miRNA RISC recruits CAF1 and
PABP to affect PABP-dependent deadenylation. Mol cell 35:868-880
45. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, Basyuk E, Bertrand E, Filipowicz
W (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science
309:1573-1576
46. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A,
Hadwiger P, Harborth J et al (2004) Therapeutic silencing of an endogenous gene by systemic
administration of modified siRNAs. Nature 432:173-178
47. Zamecnik PC, Stephenson ML (1978) Inhibition of Rous sarcoma virus replication and cell
transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A 75:280-284
48. Yi R, Qin Y, Macara IG, Cullen BR (2003) Exportin-5 mediates the nuclear export of pre-
microRNAs and short hairpin RNAs. Genes Dev 17:3011-3016
49. Zeng Y, Cullen BR (2003) Sequence requirements for micro RNA processing and function in
human cells. RNA 9:112-123
50. Franich NR, Fitzsimons HL, Fong DM, Klugmann M, During MJ, Young D (2008) AAV
vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic
rat model of Huntington's disease. Mol Ther 16:947-956
51. Koornneef A, van Logtenstein R, Timmermans E, Pisas L, Blits B, Abad X, Fortes P, Petry H,
Konstantinova P, Ritsema T (2011) AAV-mediated in vivo knockdown of luciferase using
combinatorial RNAi and U1i. Gene Ther 18:929-935
52. Ventura A, Jacks T (2009) MicroRNAs and cancer: short RNAs go a long way. Cell
136:586-591
Search WWH ::
Custom Search